547730-06-3: Terazosin EP Impurity O
Terazosin EP Impurity O (CAS No: 547730-06-3) Or 1,4-bis[(tetrahydrofuran-2-yl)carbonyl]piperazine, Terazosin EP Impurity O is an impurity of Terazosin, Terazosin Blocks postsynaptic alpha-1 receptor, which is used to treat symptoms of an enlarged prostate and high blood pressure.
Additional information on CAS 547730-06-3
Catalogue No.
VE006793
CAS No.
547730-06-3
Molecular Formula
C14H22N2O4
Molecular Weight
282.34
Parent drug
Terazosin
IUPAC Name
1, 4-bis[(tetrahydrofuran-2-yl)carbonyl]piperazine
Synonyms
N/A
References
Sci-Hub, Renewal of an old European Pharmacopoeia method for Terazosin using modeling with mass spectrometric peak tracking, 10.1016/j.jpba.2016.11.050. (2016). Retrieved January 25, 2022, from Sci-hub.ee website: https://sci-hub.ee/10.1016/j.jpba.2016.11.050 ?
Status
In-stock
Other products related to terazosin
Name of Impurity | Catalogue No. | |
---|---|---|
Terazosin EP Impurity C | VL4370002 | View CAS 60547-97-9 |
Terazosin EP Impurity D (free base ) | VL4370001 | View CAS 102714-74-9 |
Terazosin EP Impurity E | VL4370006 | View CAS 1486464-41-8 |
Terazosin EP Impurity E (free base) | VL4370003 | View CAS 102839-00-9 |
Terazosin EP Impurity L | VL4370005 | View CAS 40172-95-0 |
Terazosin EP Impurity M | VL4370004 | View CAS 31350-27-3 |
Terazosin EP Impurity N | VE008306 | View CAS 63074-07-7 |
Tetrahydrofuroic Acid | VE006494 | View CAS 16874-33-2 |